Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Federico Cappuzzo
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Concepts & Ideas
Procedures
Physiology
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
22
Bartolini, Stefania
20
Crinò, Lucio
15
Varella-Garcia, Marileila
14
Toschi, Luca
12
Ceresoli, Giovanni Luca
12
Crino, Lucio
11
Finocchiaro, Giovanna
9
Franklin, Wilbur
8
Rossi, Elisa
8
Magrini, Elisabetta
8
Hirsch, Fred
8
Gregorc, Vanesa
8
Cancellieri, Alessandra
8
Calandri, Cesare
7
Ligorio, Claudia
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Federico Cappuzzo (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Cappuzzo F; Tallini G; Finocchiaro G; Wilson R S; Ligorio C; Giordano L; Toschi L; Incarbone M; Cavina R; Terracciano L; Roncalli M; Alloisio M; Varella-Garcia M; Franklin W A; Santoro A
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(3):562-7.
-
2009: Varella-Garcia M; Diebold J; Eberhard D A; Geenen K; Hirschmann A; Kockx M; Nagelmeier I; Rüschoff J; Schmitt M; Arbogast S; Cappuzzo F
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer.
Journal of clinical pathology 2009;62(11):970-7.
-
2009: Hirsch F R; Varella-Garcia M; Cappuzzo F
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer.
Oncogene 2009;28 Suppl 1():S32-7.
-
2009: Cappuzzo Federico; Varella-Garcia Marileila; Rossi Elisa; Gajapathy Sujatha; Valente Marialuisa; Drabkin Harry; Gemmill Robert
MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(4):472-8.
-
2009: Cappuzzo F; Jänne P A; Skokan M; Finocchiaro G; Rossi E; Ligorio C; Zucali P A; Terracciano L; Toschi L; Roncalli M; Destro A; Incarbone M; Alloisio M; Santoro A; Varella-Garcia M
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(2):298-304.
-
2008: Incarbone Matteo; Ceresoli Giovanni Luca; Di Tommaso Luca; Cappuzzo Federico; Inzirillo Francesco; Infante Maurizio; Alloisio Marco
Primary pulmonary meningioma: report of a case and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):401-7.
-
2008: Crinò Lucio; Cappuzzo Federico; Zatloukal Petr; Reck Martin; Pesek Milos; Thompson Joyce C; Ford Hugo E R; Hirsch Fred R; Varella-Garcia Marileila; Ghiorghiu Serban; Duffield Emma L; Armour Alison A; Speake Georgina; Cullen Michael
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4253-60.
-
2008: Cappuzzo Federico
EGFR FISH versus mutation: different tests, different end-points.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):160-5.
-
2008: Zucali Paolo A; Ceresoli Giovanni L; Garassino Isabella; De Vincenzo Fabio; Cavina Raffaele; Campagnoli Elisabetta; Cappuzzo Federico; Salamina Silvia; Soto Parra Hector J; Santoro Armando
Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Cancer 2008;112(7):1555-61.
-
2008: Infante Maurizio; Lutman Fabio Romano; Cavuto Silvio; Brambilla Giorgio; Chiesa Giuseppe; Passera Eliseo; Angeli Enzo; Chiarenza Maurizio; Aranzulla Giuseppe; Cariboni Umberto; Alloisio Marco; Incarbone Matteo; Testori Alberto; Destro Anna; Cappuzzo Federico; Roncalli Massimo; Santoro Armando; Ravasi Gianluigi;
Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.
Lung cancer (Amsterdam, Netherlands) 2008;59(3):355-63.
-
2007: Ceresoli Giovanni L; Chiti Arturo; Zucali Paolo A; Cappuzzo Federico; De Vincenzo Fabio; Cavina Raffaele; Rodari Marcello; Poretti Dario; Lutman Fabio Romano; Santoro Armando
Assessment of tumor response in malignant pleural mesothelioma.
Cancer treatment reviews 2007;33(6):533-41.
-
2007: Toschi L; Cappuzzo F; Jänne P A
Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 9():ix150-5.
-
2007: Cappuzzo Federico; Ligorio Claudia; Jänne Pasi A; Toschi Luca; Rossi Elisa; Trisolini Rocco; Paioli Daniela; Holmes Alison J; Magrini Elisabetta; Finocchiaro Giovanna; Bartolini Stefania; Cancellieri Alessandra; Ciardiello Fortunato; Patelli Marco; Crino Lucio; Varella-Garcia Marileila
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2248-55.
-
2007: Cappuzzo Federico; Ligorio Claudia; Toschi Luca; Rossi Elisa; Trisolini Rocco; Paioli Daniela; Magrini Elisabetta; Finocchiaro Giovanna; Bartolini Stefania; Cancellieri Alessandra; Hirsch Fred R; Crino Lucio; Varella-Garcia Marileila
EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5):423-9.
-
2007: Engelman Jeffrey A; Zejnullahu Kreshnik; Mitsudomi Tetsuya; Song Youngchul; Hyland Courtney; Park Joon Oh; Lindeman Neal; Gale Christopher-Michael; Zhao Xiaojun; Christensen James; Kosaka Takayuki; Holmes Alison J; Rogers Andrew M; Cappuzzo Federico; Mok Tony; Lee Charles; Johnson Bruce E; Cantley Lewis C; Jänne Pasi A
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
Science (New York, N.Y.) 2007;316(5827):1039-43.
-
2007: Cappuzzo Federico
Predictive factors for response and for resistance to tyrosine kinase inhibitor therapy in lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5 Suppl):S12-4.
-
2007: Hirsch F R; Varella-Garcia M; Cappuzzo F; McCoy J; Bemis L; Xavier A C; Dziadziuszko R; Gumerlock P; Chansky K; West H; Gazdar A F; Crino L; Gandara D R; Franklin W A; Bunn P A
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):752-60.
-
2007: Toschi Luca; Cappuzzo Federico
Understanding the new genetics of responsiveness to epidermal growth factor receptor tyrosine kinase inhibitors.
The oncologist 2007;12(2):211-20.
-
2007: Cappuzzo F; Toschi L; Finocchiaro G; Ligorio C; Santoro A
Surrogate predictive biomarkers for response to anti-EGFR agents: state of the art and challenges.
The International journal of biological markers 2007;22(1 Suppl 4):S10-23.
-
2006: Cappuzzo Federico
Should every lung cancer patient be tested for EGFR mutation?
Expert opinion on therapeutic targets 2006;10(6):789-91.
-
2006: Travis William D; Garg Kavita; Franklin Wilbur A; Wistuba Ignacio I; Sabloff Bradley; Noguchi Masayuki; Kakinuma Ryutaro; Zakowski Maureen; Ginsberg Michelle; Padera Robert; Jacobson Francine; Johnson Bruce E; Hirsch Fred; Brambilla Elizabeth; Flieder Douglas B; Geisinger Kim R; Thunnissen Frederik; Kerr Keith; Yankelevitz David; Franks Teri J; Galvin Jeffrey R; Henderson Douglas W; Nicholson Andrew G; Hasleton Philip S; Roggli Victor; Tsao Ming-Sound; Cappuzzo Federico; Vazquez Madeline
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9 Suppl):S13-9.
-
2006: Cappuzzo F; Toschi L; Tallini G; Ceresoli G L; Domenichini I; Bartolini S; Finocchiaro G; Magrini E; Metro G; Cancellieri A; Trisolini R; Crino L; Bunn P A; Santoro A; Franklin W A; Varella-Garcia M; Hirsch F R
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(7):1120-7.
-
2006: Cappuzzo Federico; Bemis Lynne; Varella-Garcia Marileila
HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer.
The New England journal of medicine 2006;354(24):2619-21.
-
2006: Cappuzzo F; Novello S; De Marinis F; Selvaggi G; Scagliotti G V; Barbieri F; Maur M; Papi M; Pasquini E; Bartolini S; Marini L; Crinò L
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2006;52(3):319-25.
-
2006: Metro G; Cappuzzo F; Finocchiaro G; Toschi L; Crinò L
Development of gemcitabine in non-small cell lung cancer: the Italian contribution.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v37-46.
-
2006: Dziadziuszko Rafal; Witta Samir E; Cappuzzo Federico; Park Seongjin; Tanaka Koji; Danenberg Peter V; Barón Anna E; Crino Lucio; Franklin Wilbur A; Bunn Paul A; Varella-Garcia Marileila; Danenberg Kathleen D; Hirsch Fred R
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3078-84.
-
2006: Cappuzzo Federico; Finocchiaro Giovanna; Metro Giulio; Bartolini Stefania; Magrini Elisabetta; Cancellieri Alessandra; Trisolini Rocco; Castaldini Luciano; Tallini Giovanni; Crino Lucio
Clinical experience with gefitinib: an update.
Critical reviews in oncology/hematology 2006;58(1):31-45.
-
2006: Metro G; Finocchiaro G; Cappuzzo F
Anti-cancer therapy with EGFR inhibitors: factors of prognostic and predictive significance.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii42-45.
-
2006: Metro Giulio; Finocchiaro Giovanna; Toschi Luca; Bartolini Stefania; Magrini Elisabetta; Cancellieri Alessandra; Trisolini Rocco; Castaldini Luciano; Tallini Giovanni; Crino Lucio; Cappuzzo Federico
Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).
Reviews on recent clinical trials 2006;1(1):1-13.
-
2005: Cappuzzo F; Toschi L; Domenichini I; Bartolini S; Ceresoli G L; Rossi E; Ludovini V; Cancellieri A; Magrini E; Bemis L; Franklin W A; Crino L; Bunn P A; Hirsch F R; Varella-Garcia M
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.
British journal of cancer 2005;93(12):1334-40.
-
2005: Cappuzzo Federico; Varella-Garcia Marileila; Shigematsu Hisayuki; Domenichini Irene; Bartolini Stefania; Ceresoli Giovanni L; Rossi Elisa; Ludovini Vienna; Gregorc Vanesa; Toschi Luca; Franklin Wilbur A; Crino Lucio; Gazdar Adi F; Bunn Paul A; Hirsch Fred R
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5007-18.
-
2005: Cappuzzo Federico; Finocchiaro Giovanna; Trisolini Rocco; Toschi Luca; Bartolini Stefania; Metro Giulio; Crinò Lucio
Perspectives on salvage therapy for non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2005;19(8):989-95; discussion 995-6, 999, 1003-4, passim.
-
2005: Cappuzzo F; Novello S; De Marinis F; Franciosi V; Maur M; Ceribelli A; Lorusso V; Barbieri F; Castaldini L; Crucitta E; Marini L; Bartolini S; Scagliotti G V; Crinò L
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
British journal of cancer 2005;93(1):29-34.
-
2005: Cappuzzo Federico
Erlotinib in gliomas: should selection be based on EGFR and Akt analyses?
Journal of the National Cancer Institute 2005;97(12):868-9.
-
2005: Travis William D; Garg Kavita; Franklin Wilbur A; Wistuba Ignacio I; Sabloff Bradley; Noguchi Masayuki; Kakinuma Ryutaro; Zakowski Maureen; Ginsberg Michelle; Padera Robert; Jacobson Francine; Johnson Bruce E; Hirsch Fred; Brambilla Elizabeth; Flieder Douglas B; Geisinger Kim R; Thunnisen Frederik; Kerr Keith; Yankelevitz David; Franks Teri J; Galvin Jeffrey R; Henderson Douglas W; Nicholson Andrew G; Hasleton Philip S; Roggli Victor; Tsao Ming-Sound; Cappuzzo Federico; Vazquez Madeline
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(14):3279-87.
-
2005: Cappuzzo Federico; Hirsch Fred R; Rossi Elisa; Bartolini Stefania; Ceresoli Giovanni L; Bemis Lynne; Haney Jerry; Witta Samir; Danenberg Kathleen; Domenichini Irene; Ludovini Vienna; Magrini Elisabetta; Gregorc Vanesa; Doglioni Claudio; Sidoni Angelo; Tonato Maurizio; Franklin Wilbur A; Crino Lucio; Bunn Paul A; Varella-Garcia Marileila
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
Journal of the National Cancer Institute 2005;97(9):643-55.
-
2005: Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
Role of gemcitabine in cancer therapy.
Future oncology (London, England) 2005;1(1):7-17.
-
2004: Gregorc Vanesa; Ceresoli Giovanni Luca; Floriani Irene; Spreafico Anna; Bencardino Katia Bruna; Ludovini Vienna; Pistola Lorenza; Mihaylova Zhasmina; Tofanetti Francesca Romana; Ferraldeschi Massimiliano; Torri Valter; Cappuzzo Federico; Crinò Lucio; Tonato Maurizio; Villa Eugenio
Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6006-12.
-
2004: Cappuzzo Federico; Magrini Elisabetta; Ceresoli Giovanni Luca; Bartolini Stefania; Rossi Elisa; Ludovini Vienna; Gregorc Vanesa; Ligorio Claudia; Cancellieri Alessandra; Damiani Stefania; Spreafico Anna; Paties Carlo Terenzio; Lombardo Laura; Calandri Cesare; Bellezza Guido; Tonato Maurizio; Crinò Lucio
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer.
Journal of the National Cancer Institute 2004;96(15):1133-41.
-
2004: Cappuzzo Federico; Bartolini Stefania; Calandri Cesare; Crinò Lucio
Induction therapy for early-stage non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2004;18(8 Suppl 5):32-7.
-
2004: Ceresoli G L; Cappuzzo F; Gregorc V; Bartolini S; Crinò L; Villa E
Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1042-7.
-
2004: Cappuzzo F; Bartolini S; Ceresoli G L; Tamberi S; Spreafico A; Lombardo L; Gregorc V; Toschi L; Calandri C; Villa E; Crinò L
Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC).
British journal of cancer 2004;90(1):82-6.
-
2004: Cappuzzo F; Mazzoni F; Gennari A; Donati S; Salvadori B; Orlandini C; Cetto G L; Molino A; Galligioni E; Mansutti M; Tumolo S; Lucentini A; Valduga F; Bartolini S; Crinò L; Conte P F
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer.
British journal of cancer 2004;90(1):31-5.
-
2003: Cappuzzo Federico; De Marinis Filippo; Nelli Fabrizio; Calandri Cesare; Maestri Antonio; Benedetti Giovanni; Migliorino Maria Rita; Cortesi Enrico; Rastelli Francesca; Martelli Olga; Andruccetti Michele; Bartolini Stefania; Crinò Lucio
Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;42(3):355-61.
-
2003: Cappuzzo Federico; Ardizzoni Andrea; Soto-Parra Hector; Gridelli Cesare; Maione Paolo; Tiseo Marcello; Calandri Cesare; Bartolini Stefania; Santoro Armando; Crinò Lucio
Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2003;41(2):227-31.
-
2003: Cappuzzo F; Calandri C; Bartolini S; Crinò L
ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases.
British journal of cancer 2003;89(2):246-7.
-
2003: Cappuzzo Federico; Gregorc Vanesa; Rossi Elisa; Cancellieri Alessandra; Magrini Elisabetta; Paties Carlo Terenzio; Ceresoli Giovanni; Lombardo Laura; Bartolini Stefania; Calandri Cesare; de Rosa Marisa; Villa Eugenio; Crino Lucio
Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2658-63.
-
2003: Cappuzzo Federico; Selvaggi Giovanni; Gregorc Vanesa; Mazzoni Francesca; Betti Maura; Rita Migliorino Maria; Novello Silvia; Maestri Antonio; De Marinis Filippo; Darwish Samir; De Angelis Verena; Nelli Fabrizio; Bartolini Stefania; Scagliotti Giorgio V; Tonato Maurizio; Crinò Lucio
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.
Cancer 2003;98(1):128-34.
-
2003: Cappuzzo Federico; Bartolini Stefania; Crinò Lucio
Emerging drugs for non-small cell lung cancer.
Expert opinion on emerging drugs 2003;8(1):179-92.
-
2002: Cappuzzo Federico
Medical treatment of brain metastases from lung cancer.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(4):S58-9.
-
2002: Crinò Lucio; Cappuzzo Federico
New platinum derivatives in advanced non-small cell lung cancer.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2002;1(4):S24-5.
-
2002: Crinò Lucio; Cappuzzo Federico
Present and future treatment of advanced non-small cell lung cancer.
Seminars in oncology 2002;29(3 Suppl 9):9-16.
-
2002: Crinò Lucio; Cappuzzo Federico
Gemcitabine in non-small cell lung cancer.
Expert opinion on pharmacotherapy 2002;3(6):745-53.
-
2001: Crinò L; Cappuzzo F
Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settings.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 3():S45-7.
-
2001: Crino L; Cappuzzo F
[Role of gemcitabine in the treatment of advanced non-small cell lung cancer: review of the main phase II and phase III trials]
Anti-cancer drugs 2001;12 Suppl 3():S9-13.
-
2000: Cappuzzo F; Mazzoni F; Maestri A; Di Stefano A; Calandri C; Crino L
Medical treatment of brain metastases from solid tumours.
Forum (Genoa, Italy) 2000;10(2):137-48.
Sign-in to see more
